Navigation Links
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Date:3/25/2009

pital and other healthcare institutions in North America.

"This agreement highlights Galderma's commitment to the future of dermatology. Aganocide compounds have the potential to bring about significant progress in the treatment of skin diseases which affect millions of patients, without adding to the growing problem of antibiotic resistance," said Humberto C. Antunes, Chief Executive Officer of Galderma. "Galderma is glad to be working with NovaBay in this important and very promising endeavor."

"We are very pleased to have entered into this collaboration with Galderma, the world-leader in dermatology. We believe that Galderma's demonstrated development, regulatory and marketing capabilities, backed by its unrivaled reputation and track record of success, will enable NovaBay to benefit from accelerated development timelines and global commercial expertise," said Dr. Ron Najafi, Chairman and Chief Executive Officer of NovaBay. "Like our alliance with Alcon in the ophthalmic, otic and sinus fields, this agreement represents another major validation of the potential for our novel Aganocide products in treating infections caused by a wide range of bacteria, viruses and fungi."

The company's collaborations with Alcon and Galderma provide significant future revenue-generating potential for NovaBay, with favorable economic-sharing for its unique, differentiated products that address large, global dermatological and ophthalmic markets.

Conference Call

NovaBay will hold a conference call today, March 25, 2009 at 11:00 a.m. ET, to discuss its Galderma collaboration. The conference call will be simultaneously web cast on NovaBay's web site.

    Conference call details:
    Date:    Wednesday, March 25, 2009
    Time:    11:00 a.m. ET
    Dial-in (U.S.):   888-396-2384
    Dial-in (International): 617-847-8711
    Web cast:  
SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock
2. Galderma Completes Acquisition of CollaGenex
3. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
4. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
5. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
6. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
7. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
8. UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees
9. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
10. Neogen Acquires Kane Enterprises
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
(Date:1/14/2014)... MD (PRWEB) January 14, 2014 ... to developing innovative information technology solutions for patients, ... health care stakeholders, announced today the signing of ... US Food and Drug Administration (FDA). This ...
(Date:1/14/2014)... Orange, CA (PRWEB) January 14, 2014 Kerr ... a 10-minute video and additional how-to information about dual arch ... Great Restorations with Dual Arch Impressions,” the blog entry serves ... the technique and houses a step-by-step demonstration by Dr. David ...
(Date:1/14/2014)... BioMedomics, Inc. , a Point of Care ... novel disease specific POC tests, announced today that it has ... of $690,000. The investment is from private investors and is ... of private investors has significant successful experience in early investments ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2BioMedomics, Inc. Closes $690K Round of Financing 2
... June 17, 2010 An independent study has revealed,that Irish ... and consistent than a leading group of,international hypertension experts. , ... Conducted by the ... numerous blood pressure readings taken over a,24-hour period (known as ,Ambulatory Blood ...
... LEIDEN, The Netherlands and SEATTLE ... leader in the development of innovative products for,hemostasis and ... agreement with CSL Behring for the clinical and commercial ... Fibrocaps(TM).,CSL Behring is a leader in the plasma protein ...
... (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced ... Healthcare Conference in Boston on Wednesday, June 23, 2010 ... , , ... online from the investor relations page of the Company,s Web site at ...
Cached Biology Technology:Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis 2Independent Study Reveals dabl System Leads the way in Accurate Cardiovascular Diagnosis 3ProFibrix and CSL Behring Enter Into Fibrinogen and Thrombin Supply Agreement 2Accuray Incorporated to Speak at Wells Fargo Securities Healthcare Conference 2
(Date:7/9/2014)... Bacterial infections usually announce themselves with pain and fever but ... are those that are sneaky and hard to beat. Now, ... the form of tiny DNA pyramids. Published in the journal ... the nanopyramids can flag bacteria and kill more of them ... note that some infectious pathogens can lie in wait, undetectable ...
(Date:7/9/2014)... be on the verge of an economy driven by methane, ... coal and is undergoing a production boom. It has poised ... research is casting serious doubts over just how climate-friendly it ... News (C&EN), the weekly news magazine of the American ... correspondent at C&EN, explains that when burned as a fuel ...
(Date:7/9/2014)... To completely and systematically archive this body of ... in the life sciences spend a quarter of ... survey of 70 people working in biology laboratories ... Technology FIT in Sankt Augustin. Many of those ... structured approach to data collection in their workplace. ...
Breaking Biology News(10 mins):Managing the data jungle 2Managing the data jungle 3
... important techniques developed in atomic physics over the past few ... atoms and ions at temperatures just above absolute zero. Scientists ... that captured ions can also be cooled through contact with ... traps in a stable condition for longer periods of time. ...
... are sand and lakes are flats of dried mud. Are ... Earth, a planet where water covers some 70 percent of ... available to nourish life here? Scientists funded by the ... Systems (CNH) program are finding new answers. NSF-supported CNH ...
... NC The question of how life began on a ... recent mathematical research sheds light on a possible mechanism by ... soup that existed on the early Earth. Researchers have ... have gotten its start, even before the first genes or ...
Cached Biology News:Scientists from Bangalore and Mainz develop new methods for cooling of ions 2Water resources management and policy in a changing world: Where do we go from here? 2Water resources management and policy in a changing world: Where do we go from here? 3Model sheds light on the chemistry that sparked the origin of life 2
Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rab1A...
Biology Products: